Reduction of unnecessary IV antibiotic days using general criteria for antibiotic switch

References

• Ahkee S, Smith S, Newman D, Ritter W, Burke J, Ramirez J. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study. Pharmacotherapy 1997; 17: 569–75
   PubMedGoogle Scholar
• Okpara AU, Maswoswe JJ. Criteria-based antimicrobial IV to oral conversion programme. Formulary 1995; 30: 343–8
   PubMedGoogle Scholar
• Handoko KB, Asselt GJ, Overdiek JW. Onnodig lange intraveneuze antibioticatherapie voorkomen door actieve implemtatie van switchrichtlijnen. Ned Tidjdschr Geneeskd 2004; 148: 31
   Google Scholar
• Laing RBS, Mackenzie AR, Shaw H, Gould IM, Douglas JG. The Effects of IV to oral switch guidelines on the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother 1998; 42: 107–11
   PubMed Web of Science ®Google Scholar
• McLaughlin CM, Bodasing N, Boyter AC, Fenelon C, Fox JG, Seaton RA. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an interventional study. Q J Med 2005; 98: 745–52
   Google Scholar
• Ramirez JA. Advances in antibiotic use: switch therapy. Current therapeutic research. clinical and experimental 1993; 55(Suppl A)30–4
   Google Scholar
• Allen B, Naismith NW, Mauser AJ, Moulds RF. A campaign to improve the timing of conversion from intravenous to oral administration of antibiotics. Aust J Hosp Pharm 1992; 22: 434–9
   Google Scholar
• Brooks M. IV to oral antibiotic switch therapy–the Beamount experience. Irish Pharmacy Journal 1995:225–6.
   Google Scholar
• Ehrenkranz NJ, Nerenberg DE, Slater KC, Shultz JM. Intervention to discontinue parenteral antimicrobial therapy in hospitalized patients with urinary tract infection, skin and soft tissue infection, or no evident infection. Infect Control Hosp Epidemiol 1993; 14: 517–22
   PubMedGoogle Scholar
• Ramirez J, Vargas S, Ritter G, Brier M, Wright A, Smith S, et al. Early switch form intravenous to oral antibiotics and early hospital discharge. Arch Intern Med 1999; 159: 2449–54
   PubMedGoogle Scholar
• Oosterheert JJ, Bonten MJ, Schneider MME, Buskens E, Lammers JWJ, Hustnix WMN, Kramer MHH, Prins JM, Slee P, Kaasjage K, A. Hoepelman Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomized trial. BMJ 2006;333:1193.
   PubMed Web of Science ®Google Scholar
• Cuncha B. Intravenous to oral antibiotic switch therapy. Drug of Today 2001; 37: 311–9
   PubMedGoogle Scholar
• Gums JG, Yancey RW, Hamilton C, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999; 19: 1369–77
   PubMed Web of Science ®Google Scholar
• Natsch S, Kullberg BJ, Meer JW. Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Dis 1998; 17: 681–4
   PubMed Web of Science ®Google Scholar
• Hamilton-Miller JMT. Switch therapy: The theory and practice of early change from parenteral to non-parenteral antibiotic administration. Clin Microbiol Infect 1966; 2:12–19.
   Google Scholar
• Kim JH, Gallis AH. Observations on spiralling empiricism: its causes allure and perils with particular reference to antibiotic therapy. Am J Med 189;87:201–6.
   Google Scholar
• Kumarasamy Y, Cadwgan T, Gillanders IA, Jappy B, Laing R, Gould IM. Optimizing antibiotic therapy: the Aberdeen experience. Clin Microbiol Infect 2003; 9: 406–11
   PubMedGoogle Scholar
• Byl B, Clevenbergh P, Kentos A. Risk factors for inappropriate antimicrobial therapy of bacteremia, relation to outcome. Programme and abstracts of the 36th Interscience Conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology 1996.
   Google Scholar
• Finch RG. Antibiotic resistance. J Antimicrob Chemother 1998; 42: 125–8
   PubMed Web of Science ®Google Scholar
• Goldman DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the Emergence and Spread of antimicrobial-resistant Micro-organisms in Hospitals. JAMA 1996; 275(3)234–41
   PubMedGoogle Scholar
• Lawrence DE, Levin S, Balagtas R, Lowe P, Landau W, Lepper W. Ordering patterns and utilization of bacteriological laboratory reports. Arch Intern Med 1973; 132: 672–82
   Google Scholar
• Bartlett RC, Quintiliani RD, Nightingale CH, Platt D, Crowe H, Grotz R, et al. Effect of including recommendations for antimicrobial therapy in microbiology laboratory reports. Diagn Microbiol Infect Dis 1991; 14: 1657–66
   Google Scholar
• Quintiliani RD, Nightingale CH, Crowe H, Cooper B, Bartlett RC, Gousse G. Strategic antibiotic decision-making at the formulary level. Rev Infect Dis 1991; 13(Suppl 9)S770–7
   Google Scholar
• D'Espine M, Bellido F, Pechere JC, Auckenthaler R, Rohner P, Lew D, Hirschel B. Serum levels of ciprofloxacin after single oral doses in patients with septicaemia. Eur J Clin Microbiol Dis 1989; 8: 1019–23
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250
   PubMed Web of Science ®Google Scholar
• Nathan RW, Rhew DC, Murray C, Bratzler DW, Houck PM, Weingarten SR. In-hospital observation after antibiotic switch in pneumonia. Am J Med 2006; 118: 512–7
   Google Scholar
• Ramirez JA, Srinath L, Ahkee S, Huang A, Raff MJ. Early switch from intravenous to oral cephalosporins in patients with community acquired pneumonia. Arch Intern Med 1995; 155: 1273–6
   PubMed Web of Science ®Google Scholar
• Grasela TH, Paladino JA, Schentag JJ, Huepenbecker D, Rybacki J, Purcell JB, Fiedler JB. Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics. Annals of Pharmacotherapy 1991;25:857–62.
   Google Scholar
• Bernstein JM. Treatment of community acquired pneumonia–IDSA Guidelines. Chest 1999; 115: S9–13
   Google Scholar
• Owens RC, Frazer GL, Stogstill P. Antimicrobial stewardship programmes as a mean to optimize antimicrobial use. Pharmacotherapy 2004; 24: 896–908
   PubMedGoogle Scholar
• Avorn J, Soumerai SB, Taylor W, Wessel MR, Janoussek J, Weinar M. Reduction of incorrect antibiotic dosing through a structured educational program order form. Arch Intern Med 1988; 148: 1720–4
   PubMedGoogle Scholar
• Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med 1987; 82(Suppl 4A)391–4
   PubMedGoogle Scholar
• Ramirez A, Ahkee S Cost savings associated with early switch from intravenous antimicrobials to oral clarithromycin for the treatment of hospitalized patients with community acquired pneumonia. Abstracts of the 3rd International Conference on macrolides, azalides and streptogranins. Lisbon, Portugal 1996.
   Google Scholar